Urinary Tract Infection Frequency and Prescription Prophylaxis in Females and Males with Recurrent Urinary Tract Infection

• Published in: Pathogens (Basel) Vol. 12; no. 2; p. 170
• Main Authors: Goedken, Amber M, Foster, Kendra Y, Ernst, Erika J
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 21-01-2023; MDPI
• Subjects: Adults; Age; antibiotic; Antibiotics; Care and treatment; Complications and side effects; Disease prevention; Diseases; estrogen; Estrogens; Females; Gender; Health aspects; Infection control; Intubation; Kidney diseases; Males; methenamine; Methods; Observational studies; Patients; Pregnancy; Prophylaxis; Quality of life; Recurrent infection; recurrent urinary tract infection; Regression analysis; Regression models; Relapse; Urinary retention; Urinary tract; Urinary tract diseases; Urinary tract infections; Urogenital system; Vagina; Vitamin E; United States; antibiotic; estrogen; recurrent urinary tract infection; methenamine; prophylaxis
• ISSN: 2076-0817; 2076-0817
• DOI: 10.3390/pathogens12020170

Females and males with recurrent urinary tract infections may receive prescription prophylaxis to reduce the infection frequency. Little is known about how prescription prophylaxis differs between patients meeting and exceeding the minimum threshold for recurrent urinary tract infections. The objectives of this study were to estimate the association between infection frequency and receipt of prescription prophylaxis and describe the type of prescription prophylaxis initiated. This observational study used de-identified fully-insured commercial insurance data from the Midwest from 2003-2016 to identify females and males under age 64 with recurrent urinary tract infections. The patients were categorized as having three or more urinary tract infections in twelve months or only two infections in six months. Multiple logistic regression models were used to determine the association between the infection frequency and receipt of prophylaxis. The frequency of the type of prophylaxis initiated was measured. The odds of receiving prophylaxis were greater in the females and males with three or more infections compared to the patients with only two infections. Estrogen prophylaxis was initiated at a higher rate in females aged 45-63 with two infections than the females with three or more infections. Prescription prophylaxis in females and males with recurrent urinary tract infections differs between those meeting and exceeding the minimum frequency threshold.